| Health-related quality of life in lower-risk MDS patients compared with age-and sex-matched reference populations: a European LeukemiaNet study R Stauder, G Yu, KA Koinig, T Bagguley, P Fenaux, A Symeonidis, ... Leukemia 32 (6), 1380-1392, 2018 | 80 | 2018 |
| Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort A Smith, D Howell, S Crouch, D Painter, J Blase, HI Wang, A Hewison, ... International journal of epidemiology 47 (3), 700-700g, 2018 | 67 | 2018 |
| Multiple myeloma: routes to diagnosis, clinical characteristics and survival–findings from a UK population‐based study D Howell, A Smith, S Appleton, T Bagguley, U Macleod, G Cook, ... British Journal of Haematology 177 (1), 67-71, 2017 | 53 | 2017 |
| Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes L de Swart, C Reiniers, T Bagguley, C van Marrewijk, D Bowen, ... haematologica 103 (1), 69, 2018 | 45 | 2018 |
| Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome M Hoeks, T Bagguley, C van Marrewijk, A Smith, D Bowen, D Culligan, ... Leukemia 35 (6), 1745-1750, 2021 | 18 | 2021 |
| Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research Network MJE Lamb, E Roman, DA Howell, E Kane, T Bagguley, C Burton, ... BJGP open 3 (4), 2019 | 13 | 2019 |
| Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts E Roman, E Kane, D Howell, M Lamb, T Bagguley, S Crouch, D Painter, ... International Journal of Epidemiology 51 (3), e87-e94, 2022 | 10 | 2022 |
| Frontline management of nodular lymphocyte predominant Hodgkin lymphoma-a retrospective UK multicentre study MR Wilson, T Bagguley, A Smith, E Roman, R Patmore, K Hanlon, ... British journal of haematology 186 (6), e214-e217, 2019 | 10 | 2019 |
| Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort MJE Lamb, A Smith, D Painter, E Kane, T Bagguley, R Newton, D Howell, ... BMJ open 11 (2), e041296, 2021 | 9 | 2021 |
| PCN351-HEALTH-STATE UTILITY VALUES IN DIFFUSE LARGE B-CELL LYMPHOMA H Wang, A Manca, S Crouch, T Bagguley, G Yu, E Aas, D Howell, ... Value in Health 21, S74, 2018 | 8 | 2018 |
| Skeletal-related events in myeloma: a population-based study J Ashcroft, B Timothy, A Smith, HI Wang, D Howell, HA Sayala, G Cook, ... Blood 122 (21), 3158-3158, 2013 | 6 | 2013 |
| MANTLE CELL LYMPHOMA MANAGEMENT AND OUTCOME IN THE UK'S POPULATION-BASED HAEMATOLOGICAL MALIGNANCY RESEARCH NETWORK: 353 R Patmore, A Smith, J Appleton, D Howell, R Johnson, C Burton, ... Hematological Oncology 33, 269-270, 2015 | 4 | 2015 |
| S168: ERYTHROPOIETIN STIMULATION AGENTS SIGNIFICANTLY IMPROVES OUTCOME IN LOWER RISK MDS. H Garelius, A Smith, T Bagguley, A Taylor, P Fenaux, D Bowen, ... HemaSphere 6, 69-70, 2022 | 3 | 2022 |
| Labile plasma iron (LPI) is a clinical indicator of overt iron overload in patients with lower-risk myelodysplastic syndromes (MDS) from the European Leukemianet MDS registry L De Swart, C Reiniers, T Bagguley, D Bowen, J Cermak, ... Blood, The Journal of the American Society of Hematology 126 (23), 2865-2865, 2015 | 3 | 2015 |
| Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival M Hoeks, T Bagguley, R Roelofs, L De Swart, D Bowen, A Symeonidis, ... Blood 132, 4392, 2018 | 2 | 2018 |
| UK Utility Elicitation in Patients with Follicular Lymphoma H Wang, A Smith, G Yu, E Aas, T Bagguley, D Howell, E Roman, C Burton, ... Value in Health 20 (9), A449, 2017 | 2 | 2017 |
| Elevated Labile Plasma Iron Levels (LPI) and Increased Oxidative Stress Are Associated with Red Blood Cell Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes … M Hoeks, S Langemeijer, L De Swart, T Bagguley, C van Marrewijk, ... Blood, The Journal of the American Society of Hematology 128 (22), 4327-4327, 2016 | 1 | 2016 |
| S838 TRANSFUSION DEPENDENCY IS ASSOCIATED WITH PRESENCE OF TOXIC IRON SPECIES AND INFERIOR SURVIVAL IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES M Hoeks, T Bagguley, R Roelofs, L de Swart, D Bowen, A Symeonidis, ... HemaSphere 3 (S1), 373, 2019 | | 2019 |
| Matching Adjusted Indirect Comparison to Assess the Relative Efficacy of Idelalisib in Double-Refractory Follicular Lymphoma N Rajakumaraswamy, E Lovato, H Smith, T Bagguley, A Smith, R Patmore, ... Blood 132 (Supplement 1), 5842-5842, 2018 | | 2018 |
| Emergency presentation and survival from Hodgkin lymphoma M Lamb, AG Smith, E Roman, D Howell, TC Bagguley, R Patmore, ... Public Health England's Cancer Services, Data and Outcomes Conference, 2018 | | 2018 |
Alex SmithUniversity of YorkVerified email at york.ac.uk
